Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26685769

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2015 Sep
First author
Iland HJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2015 Sep;2(9):e348-9. doi: 10.1016/S2352-3026(15)00129-5.
    note
    Source null
    related pmid
    26685765
    relationship
    Comment in

Authors and identifiers

  1. name
    Iland HJ
    type
    Author
  2. name
    Collins M
    type
    Author
  3. name
    Bradstock K
    type
    Author
  4. name
    Supple SG
    type
    Author
  5. name
    Catalano A
    type
    Author
  6. name
    Hertzberg M
    type
    Author
  7. name
    Browett P
    type
    Author
  8. name
    Grigg A
    type
    Author
  9. name
    Firkin F
    type
    Author
  10. name
    Campbell LJ
    type
    Author
  11. name
    Hugman A
    type
    Author
  12. name
    Reynolds J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Iland HJ
    type
    Author
  2. name
    Collins M
    type
    Author
  3. name
    Bradstock K
    type
    Author
  4. name
    Supple SG
    type
    Author
  5. name
    Catalano A
    type
    Author
  6. name
    Hertzberg M
    type
    Author
  7. name
    Browett P
    type
    Author
  8. name
    Grigg A
    type
    Author
  9. name
    Firkin F
    type
    Author
  10. name
    Campbell LJ
    type
    Author
  11. name
    Hugman A
    type
    Author
  12. name
    Reynolds J
    type
    Author
bibliography ids
  1. nci-bib-e6ecbcffc35746253b69fcd8
book metadata
content sha256
f642b4ec01cba70d5d583ff6334a62c80831425c057d458950f3639233d1fa1b
document type
citation
dois
  1. 10.1016/S2352-3026(15)00115-5
electronic publication date
display
2015 Aug 20
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26685769
immutable id
pubmed:26685769@f642b4ec01cba70d5d583ff6334a62c80831425c057d458950f3639233d1fa1b
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
9
name
The Lancet. Haematology
nlm unique id
101643584
pages
e357-66
volume
2
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2015 Sep;2(9):e348-9. doi: 10.1016/S2352-3026(15)00129-5.
    note
    Source null
    related pmid
    26685765
    relationship
    Comment in
outcomes validated
false
pmid
26685769
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
890d0140c280129db1fb5e776df28aa95bba5bbd3df1c49aede663c472d60497
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2015 Sep
precision
month
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26685769/
title
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

Preserved source evidence · Not medical advice